Appili Therapeutics Inc (APLIF)

$0.02 +0.00 (9.76%)
Market Cap 2.18M
Revenue (ttm) 70,000.00
Net Income (ttm) -1.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,700.00%
Debt to Equity Ratio -0.84
Volume 6,800
Avg Vol 45,436
Day's Range N/A - N/A
Shares Out 121.27M
Stochastic %K 62%
Beta -0.26
Analysts Strong Buy
Price Target $0.15

Company Profile

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 902 442 4655
Address:
1344 Summer Street, Suite 21, Halifax, Canada
Bulldogs79
Bulldogs79 Nov. 14 at 4:33 PM
$APLIF This could be huge IMO. To date, Appili and its partners have secured over US$66 million in government contracts and grants, demonstrating the strength of its non-dilutive funding model. This strategic approach leverages public sector support for high-priority anti-infective and biodefense programs, providing sustainable capital to accelerate pipeline development without diluting shareholder value. By combining these historic achievements with current proposal submissions, Appili is well-positioned to advance infectious disease and biodefense products while maintaining financial flexibility.
0 · Reply
AlGo88
AlGo88 Oct. 3 at 11:48 PM
$APLIF trending in the right direction. Doesn’t take that much to move the needle.
0 · Reply
AlGo88
AlGo88 Oct. 1 at 5:42 PM
$APLIF great news. With this contract and pending government funding, it’s absurd how this is below $0.20.
0 · Reply
Bulldogs79
Bulldogs79 Oct. 1 at 3:39 PM
$APLIF Undiscovered penny stock with potential. Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases, and its partner Vitalex Biosciences (“Vitalex”) today announced that the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the National Institutes of Health, has awarded up to US$40 million in funding to support the development of VXV-01, a vaccine aimed at protecting against invasive fungal infections.
1 · Reply
Robere
Robere Sep. 23 at 9:14 PM
$APLIF
0 · Reply
AlGo88
AlGo88 Sep. 23 at 6:57 PM
$APLIF someone loading before big news?
0 · Reply
Robere
Robere Sep. 23 at 2:29 AM
$APLIF https://appilitherapeutics.com/2024/11/14/appili-therapeutics-reports-financial-and-operational-results-for-second-quarter-of-fiscal-year-2025/#:~:text=As%20of%20November%2013%2C%202024%2C%20the%20Company,Shares%2C%2011%2C520%2C281%20stock%20options%2C%20and%2041%2C356%2C874%20warrants
0 · Reply
Robere
Robere Sep. 22 at 5:15 PM
$APLIF that should tell you
2 · Reply
Robere
Robere Sep. 18 at 3:21 PM
$APLIF three nice buys coming in should be some news soon
0 · Reply
Robere
Robere Sep. 11 at 9:54 PM
$APLIF
1 · Reply
Latest News on APLIF
No data available.
Bulldogs79
Bulldogs79 Nov. 14 at 4:33 PM
$APLIF This could be huge IMO. To date, Appili and its partners have secured over US$66 million in government contracts and grants, demonstrating the strength of its non-dilutive funding model. This strategic approach leverages public sector support for high-priority anti-infective and biodefense programs, providing sustainable capital to accelerate pipeline development without diluting shareholder value. By combining these historic achievements with current proposal submissions, Appili is well-positioned to advance infectious disease and biodefense products while maintaining financial flexibility.
0 · Reply
AlGo88
AlGo88 Oct. 3 at 11:48 PM
$APLIF trending in the right direction. Doesn’t take that much to move the needle.
0 · Reply
AlGo88
AlGo88 Oct. 1 at 5:42 PM
$APLIF great news. With this contract and pending government funding, it’s absurd how this is below $0.20.
0 · Reply
Bulldogs79
Bulldogs79 Oct. 1 at 3:39 PM
$APLIF Undiscovered penny stock with potential. Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases, and its partner Vitalex Biosciences (“Vitalex”) today announced that the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the National Institutes of Health, has awarded up to US$40 million in funding to support the development of VXV-01, a vaccine aimed at protecting against invasive fungal infections.
1 · Reply
Robere
Robere Sep. 23 at 9:14 PM
$APLIF
0 · Reply
AlGo88
AlGo88 Sep. 23 at 6:57 PM
$APLIF someone loading before big news?
0 · Reply
Robere
Robere Sep. 23 at 2:29 AM
$APLIF https://appilitherapeutics.com/2024/11/14/appili-therapeutics-reports-financial-and-operational-results-for-second-quarter-of-fiscal-year-2025/#:~:text=As%20of%20November%2013%2C%202024%2C%20the%20Company,Shares%2C%2011%2C520%2C281%20stock%20options%2C%20and%2041%2C356%2C874%20warrants
0 · Reply
Robere
Robere Sep. 22 at 5:15 PM
$APLIF that should tell you
2 · Reply
Robere
Robere Sep. 18 at 3:21 PM
$APLIF three nice buys coming in should be some news soon
0 · Reply
Robere
Robere Sep. 11 at 9:54 PM
$APLIF
1 · Reply
AlGo88
AlGo88 Sep. 11 at 4:25 PM
$APLIF would be nice if they were acquired for $15M
0 · Reply
miop
miop Aug. 30 at 1:42 PM
$APLIF mop
0 · Reply
Robere
Robere Aug. 18 at 11:11 PM
$APLIF this was released early today. There’s more to read. You just have to find it just posting a snippet.
2 · Reply
Scottohmac
Scottohmac Aug. 7 at 9:25 PM
$APLIF https://finance.yahoo.com/news/appili-therapeutics-colleagues-publish-manuscript-112100092.html
0 · Reply
Scottohmac
Scottohmac Aug. 7 at 7:08 PM
$APLIF the 🇨🇦 chart looks much nicer
0 · Reply
Robere
Robere Jul. 14 at 11:57 PM
$APLIF 1801 is waiting for a submission sometime this year 2025???
0 · Reply
AlGo88
AlGo88 Jul. 14 at 3:26 PM
$APLIF who knows..maybe with luck this will merge for some crypto HYPE treasury like $PURR or $BMNR and get to $0.50. 🤔
1 · Reply
AlGo88
AlGo88 Jul. 2 at 6:23 PM
$APLIF will we see $0.03 again?
1 · Reply
Bulldogs79
Bulldogs79 Jul. 1 at 7:31 PM
$APLIF Sounds good. “The recent commercial re-launch of LIKMEZ® (ATI-1501), following new patent coverage through to 2039, marked a major milestone for Appili and our partner, Saptalis Pharmaceuticals, LLC (“Saptalis”). Appili was founded to develop ATI-1501, and it’s rewarding to see our lead development program in the market,” said Don Cilla, Pharm.D., M.B.A., President and CEO of Appili Therapeutics. “As we look to fiscal 2026, we remain focused on driving continued sales of LIKMEZ, advancing ATI-1701 funded activities, and finalizing development plans for ATI-1801. In addition, Appili has submitted five non-dilutive funding proposals to the U.S. government, totaling up to US$125 million.”
0 · Reply
Robere
Robere Jun. 30 at 10:26 AM
$APLIF June 25th update there is more yet I only copied partial Enjoy
1 · Reply
Scottohmac
Scottohmac Jun. 23 at 5:32 PM
$APLIF can’t get much lower now. This has got to but worth .10 on speculation alone.
1 · Reply
Robere
Robere May. 22 at 12:30 AM
$APLIF Ati -1801 (Topical Paromomycin have a submission this year sometime in 2025?
0 · Reply